首页> 外文期刊>Clinical nuclear medicine >Angiomatoid fibrous histiocytoma: staging and evaluation of response to therapy with F-18 FDG PET/CT.
【24h】

Angiomatoid fibrous histiocytoma: staging and evaluation of response to therapy with F-18 FDG PET/CT.

机译:血管瘤样纤维组织细胞瘤:分期和评估F-18 FDG PET / CT对治疗的反应。

获取原文
获取原文并翻译 | 示例
           

摘要

Angiomatoid fibrous histiocytoma is a very rare tumor that accounts for 0.3% of all soft-tissue tumors, and occurs predominantly in the extremities of adolescents and young adults. It has been classified by the World Health Organization as a tumor of uncertain differentiation with intermediate malignant potential, although recent evidence suggests a myoid or myofibroblastic cell origin. Most examples behave in an indolent manner with a regional recurrence rate of 15% and a rate of metastasis of 1%. We present a 29-year-old woman who was referred for an F-18 FDG PET/CT to evaluate a left shoulder mass. She had multiple local FDG-avid lymph nodes, and initial biopsy was suggestive of epithelioid sarcoma. She was treated with chemotherapy, but a post-therapy PET/CT showed minimal response and radical surgical excision was performed. The histopathology and immu-nohistochemistry was consistent with angiomatoid fibrous histiocytoma. This case highlights a potential new utility for F-18 FDG PET/CT in the staging and evaluation of response to therapy for this very rare soft-tissue tumor.
机译:血管瘤样纤维组织细胞瘤是一种非常罕见的肿瘤,占所有软组织肿瘤的0.3%,主要发生在青少年和年轻人的四肢。尽管最近的证据表明它是肌样或肌成纤维细胞起源,但世界卫生组织已将其分类为分化不确定,具有中等恶性潜能的肿瘤。大多数例子表现为轻度行为,区域复发率为15%,转移率为1%。我们介绍了一位29岁的妇女,她被转介F-18 FDG PET / CT评估左肩质量。她有多个局部FDG-avid淋巴结,初步活检提示上皮样肉瘤。她接受了化学疗法的治疗,但治疗后的PET / CT表现出最小的反应,并进行了根治性手术切除。组织病理学和免疫组化与血管瘤样纤维组织细胞瘤一致。该病例突显了F-18 FDG PET / CT在这种非常罕见的软组织肿瘤的分期和对治疗反应的评估中潜在的新用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号